Nephron Pharmaceuticals

IPRATROPIUM BROMIDE - Cost

Last Updated: April 1st, 2024

HCPCS:

J7644

HCPCS Code Descriptor:

Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram

Medicare Payment Limit:

The IPRATROPIUM BROMIDE Medicare Payment Limit is $0.331

Average Sale Price:

IPRATROPIUM BROMIDE ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The IPRATROPIUM BROMIDE Medicare Co-insurance percentage is 20%. IPRATROPIUM BROMIDE's Medicare Co-insurance amount is $0.07 per HCPCS unit.

APC Code:

The Ipratropium Bromide APC Code is: not available

APC Payment Limit:

The APC Payment Limit for IPRATROPIUM BROMIDE is not available.

Ipratropium Bromide Cost Information:

IPRATROPIUM BROMIDE, a product of Nephron Pharmaceuticals, became effective on January 1, 2007, and is associated with HCPCS J7644. There are 17 NDCs aligned to J7644. Pricing since 2022 has been relatively constant with the exception of AWP which increased significantly by over 250%.

ACCESS PRICING AND MORE BY REGISTERING

Ipratropium Bromide’s wholesale acquisition cost (WAC) information was last updated on:
January 2, 2024
Ipratropium Bromide’s average wholesale price (AWP) information was last updated on:
May 1, 2023